Accenture (NYSE:ACN) had its price objective increased by stock analysts at Barclays from $152.00 to $154.00 in a research report issued on Friday. The firm currently has an “equal weight” rating on the information technology services provider’s stock. Barclays’ price target points to a potential upside of 1.10% from the stock’s previous close.

A number of other equities research analysts have also weighed in on ACN. Zacks Investment Research upgraded Accenture from a “hold” rating to a “buy” rating and set a $165.00 price objective for the company in a research note on Tuesday, November 28th. Robert W. Baird restated a “hold” rating and set a $155.00 price objective on shares of Accenture in a research note on Thursday, December 7th. Deutsche Bank raised their price objective on Accenture to $165.00 in a research note on Monday, December 11th. Cowen restated a “buy” rating and set a $165.00 price objective on shares of Accenture in a research note on Thursday, December 14th. Finally, SunTrust Banks restated a “hold” rating and set a $164.00 price objective on shares of Accenture in a research note on Thursday, December 21st. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and thirteen have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $159.91.

How to Become a New Pot Stock Millionaire

Shares of Accenture (NYSE:ACN) traded up $2.09 during trading hours on Friday, hitting $152.32. The company had a trading volume of 1,980,119 shares, compared to its average volume of 2,387,895. The stock has a market cap of $102,934.09, a P/E ratio of 26.96, a P/E/G ratio of 2.43 and a beta of 1.01. Accenture has a 1-year low of $114.82 and a 1-year high of $165.58.

Accenture (NYSE:ACN) last issued its quarterly earnings data on Thursday, March 22nd. The information technology services provider reported $1.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.09. Accenture had a return on equity of 41.79% and a net margin of 9.43%. The firm had revenue of $9.59 billion during the quarter, compared to analyst estimates of $9.31 billion. During the same quarter last year, the firm earned $1.33 EPS. Accenture’s quarterly revenue was up 15.2% on a year-over-year basis. research analysts forecast that Accenture will post 6.66 earnings per share for the current fiscal year.

In other Accenture news, insider Gianfranco Casati sold 5,000 shares of Accenture stock in a transaction on Tuesday, December 26th. The stock was sold at an average price of $152.92, for a total transaction of $764,600.00. Following the sale, the insider now owns 46,202 shares of the company’s stock, valued at approximately $7,065,209.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Richard P. Clark sold 1,433 shares of Accenture stock in a transaction on Wednesday, January 10th. The shares were sold at an average price of $158.37, for a total value of $226,944.21. Following the sale, the chief accounting officer now directly owns 8,932 shares in the company, valued at approximately $1,414,560.84. The disclosure for this sale can be found here. Insiders have sold a total of 117,249 shares of company stock worth $18,106,228 in the last ninety days. 0.21% of the stock is owned by company insiders.

A number of institutional investors have recently made changes to their positions in ACN. Chemical Bank raised its stake in shares of Accenture by 5.3% in the 4th quarter. Chemical Bank now owns 33,990 shares of the information technology services provider’s stock worth $5,204,000 after buying an additional 1,700 shares in the last quarter. Wagner Wealth Management LLC bought a new stake in shares of Accenture in the 4th quarter worth $179,000. Colonial Trust Advisors raised its stake in shares of Accenture by 39.2% in the 4th quarter. Colonial Trust Advisors now owns 46,129 shares of the information technology services provider’s stock worth $7,062,000 after buying an additional 12,992 shares in the last quarter. Xact Kapitalforvaltning AB raised its stake in shares of Accenture by 6.0% in the 4th quarter. Xact Kapitalforvaltning AB now owns 129,257 shares of the information technology services provider’s stock worth $19,788,000 after buying an additional 7,343 shares in the last quarter. Finally, Envestnet Asset Management Inc. raised its stake in shares of Accenture by 3.4% in the 4th quarter. Envestnet Asset Management Inc. now owns 266,793 shares of the information technology services provider’s stock worth $40,843,000 after buying an additional 8,660 shares in the last quarter. 75.57% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: This piece was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another domain, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this piece can be viewed at https://www.watchlistnews.com/accenture-acn-price-target-increased-to-154-00-by-analysts-at-barclays/1960887.html.

Accenture Company Profile

Accenture plc is a professional services company serving clients in various industries and in geographic regions, including North America, Europe and Growth Markets. The Company provides management and technology consulting services. Its segments include Communications, Media and Technology; Financial Services; Health and Public Service; Products, and Resources.

Analyst Recommendations for Accenture (NYSE:ACN)

Receive News & Ratings for Accenture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture and related companies with MarketBeat.com's FREE daily email newsletter.